- Home
- FA vs BCRX Comparison
FA vs BCRX Comparison
Compare FA & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FA | BCRX |
|---|---|---|
| Founded | 2003 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.6B |
| IPO Year | 2021 | 1995 |
Fundamental Metrics
Financial Performance| Metric | FA | BCRX |
|---|---|---|
| Price | $12.10 | $8.50 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 11 |
| Target Price | $15.50 | ★ $20.82 |
| AVG Volume (30 Days) | 1.5M | ★ 4.0M |
| Earning Date | 01-01-0001 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 72.97 | ★ 381.40 |
| EPS | N/A | ★ 1.21 |
| Revenue | ★ $1,574,389,000.00 | $25,186,000.00 |
| Revenue This Year | $8.11 | N/A |
| Revenue Next Year | $7.34 | $12.55 |
| P/E Ratio | ★ N/A | $7.00 |
| Revenue Growth | ★ 83.02 | N/A |
| 52 Week Low | $8.82 | $6.00 |
| 52 Week High | $19.01 | $11.31 |
Technical Indicators
Market Signals| Indicator | FA | BCRX |
|---|---|---|
| Relative Strength Index (RSI) | 54.07 | 69.72 |
| Support Level | $8.82 | $7.95 |
| Resistance Level | $14.56 | $8.68 |
| Average True Range (ATR) | 0.65 | 0.33 |
| MACD | 0.40 | 0.12 |
| Stochastic Oscillator | 82.45 | 81.19 |
Price Performance
Historical ComparisonAbout FA First Advantage Corporation
First Advantage Corp is a provider of global software and data in the Human Resources technology industry. The company leverages proprietary technology and AI across its platforms, data, and APIs to deliver comprehensive background screening, digital identity, and verification solutions driven by innovation, automation, and customer success. Its reportable segments are First Advantage Americas, First Advantage International, and Sterling. Maximum revenue is generated from the First Advantage Americas segment. The group serves customers in over 200 countries and territories, modernising hiring and onboarding on a global scale.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.